Uniqsis has developed an extensive range of affordable ‘building block’ modules to which you can simply add your own pumps to create a flow chemistry system.

Agreement is part of Veracyte’s multi-platform strategy for its decentralized IVD tests outside of the U.S.

Proteintech Genomics, a subsidiary of Proteintech Group, inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail.

Assays focus on accelerating cancer research.

SGD Pharma, announces its commitment to company-wide emissions reductions as part of its decarbonization strategy by joining the Science Based Targets initiative (SBTi).

Armis Biopharma, Inc. announced that the company received a $20.3 million contract from the Defense Threat Reduction Agency (DTRA) to develop its proprietary Veriox® DECON chemical warfare agent (CWA) decontamination product.

Our packed agenda will highlight how the Oxford Nanopore platform can generate richer data revealing enhanced biological insights not possible with short read sequencing – or other sequencing platforms – to accelerate research into human disease.

The partners will offer an integrated sample-to-report rapid nanopore sequencing analysis platform for neonatal/paediatric intensive care units to support clinicians in acute settings.

CEO Gordon Sanghera discusses how Apple’s latest product announcement means complex processing required for DNA/RNA sequencing can now be run from the latest MacBook Pro™ or iMac ™.

Consortium aims to share best practices and increase our understanding of genetic disease.